Jobelyn® ameliorates neurological deficits in rats with ischemic stroke through inhibition of release of pro-inflammatory cytokines and NF-κB signaling pathway

Pathophysiology (2019) - Comment
pubmed: 30413288 doi: 10.1016/j.pathophys.2018.10.002 issn: 0928-4680

Solomon Umukoro, Ejiroghene E Oghwere, Benneth Ben-Azu, Olatunde Owoeye, Abayomi M Ajayi, Osarume Omorogbe, Olajuwon Okubena